Literature DB >> 25526711

The complex relationship between bone remodeling and the physical and material properties of bone.

D B Burr1.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 25526711     DOI: 10.1007/s00198-014-2970-4

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  26 in total

Review 1.  How can bone turnover modify bone strength independent of bone mass?

Authors:  C J Hernandez
Journal:  Bone       Date:  2008-02-20       Impact factor: 4.398

2.  Stiffness of compact bone: effects of porosity and density.

Authors:  M B Schaffler; D B Burr
Journal:  J Biomech       Date:  1988       Impact factor: 2.712

3.  Advanced glycation end products (AGEs), but not high glucose, inhibit the osteoblastic differentiation of mouse stromal ST2 cells through the suppression of osterix expression, and inhibit cell growth and increasing cell apoptosis.

Authors:  Kyoko Okazaki; Toru Yamaguchi; Ken-Ichiro Tanaka; Masakazu Notsu; Noriko Ogawa; Shozo Yano; Toshitsugu Sugimoto
Journal:  Calcif Tissue Int       Date:  2012-08-18       Impact factor: 4.333

4.  Effects of preexisting microdamage, collagen cross-links, degree of mineralization, age, and architecture on compressive mechanical properties of elderly human vertebral trabecular bone.

Authors:  Helene Follet; Stéphanie Viguet-Carrin; Brigitte Burt-Pichat; Baptiste Dépalle; Yohann Bala; Evelyne Gineyts; Francoise Munoz; Monique Arlot; Georges Boivin; Roland D Chapurlat; Pierre D Delmas; Mary L Bouxsein
Journal:  J Orthop Res       Date:  2010-10-18       Impact factor: 3.494

5.  Advanced glycation end products and bone loss during aging.

Authors:  Patrizio Odetti; Simona Rossi; Fiammetta Monacelli; Alessia Poggi; Maria Cirnigliaro; Marcello Federici; Alberto Federici
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

6.  Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate.

Authors:  S Y Tang; M R Allen; R Phipps; D B Burr; D Vashishth
Journal:  Osteoporos Int       Date:  2008-10-11       Impact factor: 4.507

7.  HMGB1 regulates RANKL-induced osteoclastogenesis in a manner dependent on RAGE.

Authors:  Zheng Zhou; Jun-Yan Han; Cai-Xia Xi; Jian-Xin Xie; Xu Feng; Cong-Yi Wang; Lin Mei; Wen-Cheng Xiong
Journal:  J Bone Miner Res       Date:  2008-07       Impact factor: 6.741

8.  Non-enzymatic glycation alters microdamage formation in human cancellous bone.

Authors:  S Y Tang; D Vashishth
Journal:  Bone       Date:  2009-09-09       Impact factor: 4.398

9.  The resistance of cortical bone tissue to failure under cyclic loading is reduced with alendronate.

Authors:  Devendra Bajaj; Joseph R Geissler; Matthew R Allen; David B Burr; J C Fritton
Journal:  Bone       Date:  2014-04-01       Impact factor: 4.398

10.  Age-related changes in the human femoral cortex.

Authors:  E D Simmons; K P Pritzker; M D Grynpas
Journal:  J Orthop Res       Date:  1991-03       Impact factor: 3.494

View more
  2 in total

Review 1.  Bone Quality in Chronic Kidney Disease: Definitions and Diagnostics.

Authors:  Erin M B McNerny; Thomas L Nickolas
Journal:  Curr Osteoporos Rep       Date:  2017-06       Impact factor: 5.096

Review 2.  Rethinking Bone Disease in Kidney Disease.

Authors:  Matthew J Damasiewicz; Thomas L Nickolas
Journal:  JBMR Plus       Date:  2018-11-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.